Dr Eileen Dunne

Senior Research Officer
Infection and Immunity
Murdoch Childrens Research Institute
Australia

Academician Pediatrics
Biography

Dr Eileen Dunne completed a PhD in microbiology from the Boston University School of Medicine in 2010. Her thesis research involved investigating the mechanisms of action of a synthetic antimicrobial peptide on Gram-positive bacteria. Prior to graduate school, she spent two years in Nicaragua as a member of the Peace Corps and worked at the Harvard School of Public Health. She joined the Pneumococcal Research group at Murdoch Childrens as a postdoctoral scientist in 2010, aiming to apply her background as a molecular microbiologist to research with a focus on international child health. Dr Dunne became a Senior Research Officer in 2012 and is currently involved in several international collaborations supporting the use of pneumococcal vaccines in resource-limited settings. She is a co-investigator on grants totalling over $11 million from funders including GAVI and the Bill and Melinda Gates Foundation.

Research Intrest

 Streptococcus pneumoniae and other respiratory pathogens in children.

List of Publications
Dunne EM, Tikkanen L, Balloch A, Gould K, Yoannes M, Phuanukoonnon S, Licciardi PV, Russell FM, Mulholland EK, Satzke C, Hinds J. Characterization of 19A-like 19F pneumococcal isolates from Papua new Guinea and Fiji. New microbes and new infections. 2015 Sep 30;7:86-8.
Boelsen LK, Dunne EM, Lamb KE, Bright K, Cheung YB, Tikoduadua L, Russell FM, Mulholland EK, Licciardi PV, Satzke C. Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes. Vaccine. 2015 Oct 13;33(42):5708-14.
Satzke C, Dunne EM, Porter BD, Klugman KP, Mulholland EK. The PneuCarriage project: a multi-centre comparative study to identify the best serotyping methods for examining pneumococcal carriage in vaccine evaluation studies. PLoS medicine. 2015 Nov 17;12(11):e1001903.